Eye-Sparing Treatment for Diffuse Invasive Conjunctival Melanoma

Leandro J. Chaves, Bradley Huth, James J. Augsburger, Zelia M. Correa

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


The management of patients with diffuse invasive conjunctival melanoma focuses on local tumor control and screening for metastasis. Despite the lack of consensus on the benefit of sentinel lymph node biopsy for these neoplasms, the information obtained by histopathology is useful for tumor staging and treatment planning. Due to the lack of evidence of survival improvement, orbital exenteration is being performed with diminishing frequency. We describe a patient with diffuse invasive conjunctival melanoma and lymph node involvement treated by tumor debulking, brachytherapy (custom unshielded radioactive device), and adjuvant ipilimumab who has had a favorable outcome without emergence of local tumor relapse or distant metastasis during 16 months of follow up.

Original languageEnglish (US)
Pages (from-to)261-266
Number of pages6
JournalOcular Oncology and Pathology
Issue number4
StatePublished - Jun 1 2018


  • Brachytherapy
  • Enucleation
  • Melanoma, conjunctiva
  • Melanoma, eye

ASJC Scopus subject areas

  • Nursing(all)


Dive into the research topics of 'Eye-Sparing Treatment for Diffuse Invasive Conjunctival Melanoma'. Together they form a unique fingerprint.

Cite this